 | Up a level |
Journal Article
Limmroth, V., Haverkamp, W., Dechend, R., Kleiter, I., Wagner, B., Schmidt, S., Lassek, C., Wendt, G. and Ziemssen, T. (2017). First dose effects of fingolimod: final results of an in-depth ECG and Holter study in 6,998 German RRMS patients. Mult. Scler. J., 23. S. 383 - 385. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970
Limmroth, V., Haverkamp, W., Dechend, R., Lang, M., Haas, J., Wagner, B., Richter, S., Schieb, H., Wendt, G. and Ziemssen, T. (2016). First dose effects of fingolimod: in depth electrocardiographic analysis of over 4.700 patients confirms first dose observation is usually uneventful. Mult. Scler. J., 22. S. 356 - 357. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970
Mansfield, C., Buyandelger, B., Kostin, S., Knoell, G., Toliat, M. R., Perrot, A., Haverkamp, W., Milting, H., Nurnberg, P. and Knoell, R. (2014). The role of MIP1 in cardiac myocyte hypertrophy and survival. Cardiovasc. Res., 103. OXFORD: OXFORD UNIV PRESS. ISSN 1755-3245